Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study.

Abstract

BACKGROUND AND AIMS:

Lactulose is a common food ingredient and widely used as a treatment for constipation or hepatic encephalopathy and a substrate for hydrogen breath tests. Lactulose is fermented by the colon microbiota resulting in the production of hydrogen (H2). H2 is a substrate for enteropathogens including Salmonella Typhimurium (S. Typhimurium) and increased H2 production upon lactulose ingestion might favor the growth of H2-consuming enteropathogens. We aimed to analyze effects of single-dose lactulose ingestion on the growth of intrinsic Escherichia coli (E. coli), which can be efficiently quantified by plating and which share most metabolic requirements with S. Typhimurium.

METHODS:

32 healthy volunteers (18 females, 14 males) were recruited. Participants were randomized for single-dose ingestion of 50 g lactulose or 50 g sucrose (controls). After ingestion, H2 in expiratory air and symptoms were recorded. Stool samples were acquired at days -1, 1 and 14. We analyzed 16S microbiota composition and abundance and characteristics of E. coli isolates.

RESULTS:

Lactulose ingestion resulted in diarrhea in 14/17 individuals. In 14/17 individuals, H2-levels in expiratory air increased by ≥20 ppm within 3 hours after lactulose challenge. H2-levels correlated with the number of defecations within 6 hours. E. coli was detectable in feces of all subjects (2 x 10(2)-10(9) CFU/g). However, the number of E. coli colony forming units (CFU) on selective media did not differ between any time point before or after challenge with sucrose or lactulose. The microbiota composition also remained stable upon lactulose exposure.

CONCLUSION:

Ingestion of a single dose of 50 g lactulose does not significantly alter E. coli density in stool samples of healthy volunteers. 50 g lactulose therefore seems unlikely to sufficiently alter growth conditions in the intestine for a significant predisposition to infection with H2-consuming enteropathogens such as S. Typhimurium (www.clinicaltrials.gov NCT02397512).

• Authors: Sandra Y Wotzka, Markus Kreuzer, Lisa Maier, Mirjam Zünd, Markus Schlumberger, Bidong Nguyen, Mark Fox, Daniel Pohl, Henriette Heinrich, Gerhard Rogler, Luc Biedermann, Michael Scharl, Shinichi Sunagawa, Wolf-Dietrich Hardt, Benjamin Misselwitz
• Journal: PloS one (PLoS One) Vol. 13 Issue 10 Pg. e0206214 ( 2018) ISSN: 1932-6203 [Electronic] United States
• PMID: 30359438 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Dietary Sucrose
• Lactulose

Topics

• Adult
• Colon (drug effects, microbiology)
• Diarrhea (chemically induced, microbiology)
• Dietary Sucrose (pharmacology)
• Dose-Response Relationship, Drug
• Feces (microbiology)
• Female
• Gastrointestinal Microbiome (drug effects)
• Healthy Volunteers
• Humans
• Lactulose (pharmacology)
• Male
• Microbial Viability (drug effects)
• Middle Aged
• Young Adult